Tislelizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of tislelizumab that can be used for the treatment of cancer of the nasopharynx, esophageal squamous cell carcinoma (ESCC), appendiceal adenocarcinoma, small bowel adenocarcinoma, colorectal cancer, anal carcinoma, and hepatocellular carcinoma.

**Synonyms:** - Tevimbra Regimen - Tislelizumab monotherapy - Tislelizumab-jsgr Regimen